IUBio Biosequences .. Software .. Molbio soft .. Network News .. FTP

Call for abstracts: Symp. of Canadian Soc. Pharmaceutical Sciences

c. miller rellim at MAILHOST.TCS.TULANE.EDU
Tue Apr 6 11:03:41 EST 1999


2nd Annual Symposium of the Canadian Society for Pharmaceutical
Sciences (CSPS)

Friday, August 27th, 1999 & Saturday, August 28th, 1999
 Le Centre Sheraton Hotel, Montreal, Quebec, Canada
"Exploring Human Diversity in Drug Development and Pharmacotherapy"

Programme Topics

Pharmaceutical Research and Drug Development in the New
Millennium.

New Advances in Human Diversity.
This section will highlight important new advances in our
understanding of individual factors involved in pharmacokinetic and
pharmacodynamic variability. Speakers will focus on the contributing
role of age, gender, disease and genetic polymorphism in intersubject
variability.

The New Era of Pharmacogenomics
This section will concentrate on methods involved in
pharmacogenetic studies as well as the clinical application of
pharmacogenetic research. Speaker topics will introduce the audience
to pharmacogenetics, pharmacogenomics, proteomics and bioinformation
sources in drug development, subject selection and clinical study
design.

Subject Selection in Drug Testing.
This section will provide an in depth discussion on subject
selection in clinical trials with a focus on regulatory aspects.
Issues pertaining to inter- and intra- subject variability in
bioequivalency studies and current views on the inclusion of women and
other targeted patient groups in clinical trials will be presented.
The audience will have the opportunity to critically discuss current
regulatory perspectives on these issues.

Challenges of Drug Delivery to Targeted Patients.
This section will summarize issues encountered in drug delivery
to special population groups with emphasis on pediatric, geriatric and
palliative care patients. Speakers will provide examples and address
special concerns of drug delivery to these patients. This symposium
will also include a discussion on novel advances in the use of gene
therapy to treat diseases such as cystic fibrosis.

Programme, registration, and abstract/poster information is posted on the
website.
http://www.ualberta.ca/~csps

CSPS Call for Abstracts/Posters

"Exploring Human Diversity In Drug Development and Pharmacotherapy"

Abstracts and posters are being accepted for the 2nd Symposium of the
Canadian Society for Pharmaceutical Sciences in Montreal, Quebec,
Canada. The deadline for submission is June 25th, 1999, and authors
will be informed of acceptance by July 5th, 1999. Posters presented
elsewhere within the last 12 months are acceptable. Abstracts may be
submitted in either English or French and must contain an adequate
body of data with the Purpose, Methods, Results and Conclusion
headings. The length of the poster must be between 250 to 500 words
with the title in capital letters and the name of the presenter
underlined. Abstracts may be submitted electronically online, or by
email.

Work that has been presented elsewhere must be clearly acknowledged
 with the name of the meeting, the date of the original presentation,
and referenced to the publication if abstract has been published.
Posters will be displayed on both days of the conference, and authors
must be present to discuss their work during all four break periods.
To present a paper or poster, please indicate so on the Notice of
Intention Page.
http://www.pharmacy.ualberta.ca/CSPSConferenceSite/intention.htm

Sandra Hutt, Administrator
 Canadian Society for Pharmaceutical Sciences
"Journal of Pharmacy & Pharmaceutical Sciences"
3118 Dentistry/Pharmacy Centre
University of Alberta Campus
Edmonton, Alberta, Canada, T6G 2N8
Tel: (780) 492-0950
Fax: (780) 492-0951
http://www.ualberta.ca/~csps
mailto:Sandra.Hutt at ualberta.ca





More information about the Toxicol mailing list

Send comments to us at biosci-help [At] net.bio.net